Autres domaines


Mechanism of topical glucocorticoid treatment of hay fever: IL-5 and eosinophil activation during natural allergen exposure are suppressed, but IL-4, IL-6, and IgE antibody production are unaffected

Doi : 10.1067/mai.2000.108430 

Hirohito Kita, MD, Ronald K. Jorgensen, MD, Charles E. Reed, MD, Sandra L. Dunnette, BA, Mark C. Swanson, BA, Kathleen R. Bartemes, BA, Diane Squillace, BA, Judy Blomgren, RN, Kay Bachman, RN, BSN, Gerald J. Gleich, MD

Voir les affiliations


Background: Allergic rhinitis is traditionally defined as an IgE- and mast cell–mediated hypersensitivity reaction. Allergen challenge models suggest that cytokines and eosinophil mediators may also play roles. However, the causal relationship among inflammatory cells, their products, and patients’ symptoms during natural allergen exposure has not been established. Objective: We sought to elucidate the mechanisms of seasonal allergic rhinitis and the beneficial effects of topical glucocorticoids. Methods: Thirty patients with ragweed-induced hay fever and a strongly positive serologic test response for ragweed IgE antibody received budesonide nasal spray or placebo in a randomized, parallel, double-blind study. Nasal wash fluids and sera were collected before and during the hay fever season. The levels of inflammatory mediators and allergen-specific immunoglobulins were measured by immunoassay. The activation markers on blood eosinophils were quantitated by flow cytometry. Results: Compared with placebo-treated patients, budesonide-treated patients had strikingly reduced symptoms. In the placebo group, nasal symptoms correlated with nasal lavage fluid eosinophil-derived neurotoxin and IL-5 levels. At the season peak, the budesonide-treated group had significantly lower nasal fluid eosinophil-derived neurotoxin, IL-5, and soluble intracellular adhesion molecule-1 levels. In the treated group eosinophil expression of CD11b was suppressed at the season peak. In contrast, levels of IL-4 and IL-6 in nasal fluid and the seasonal increases in serum ragweed-specific IgE and nasal fluid IgA antibodies did not differ between groups. Conclusion: Eosinophilic inflammation plays a critical role in seasonal allergic rhinitis symptoms. One of the therapeutic effects of glucocorticoids is to suppress this inflammation. (J Allergy Clin Immunol 2000;106:521-9.)

Le texte complet de cet article est disponible en PDF.

Keywords : Allergic rhinitis, topical budesonide, cytokines, eosinophils, adhesion molecules, IgE, secretory IgA

Abbreviations : EDN:, ICAM-1:, MBP:


 Supported in part by grants from Astra Pharmaceuticals (Westborough, Mass), grants from the National Institutes of Health (AI 34577 and AI 34486), and the Mayo Foundation.
 Reprint requests: Hirohita Kita, MD, Department of Immunology, Mayo Clinic and Foundation, Rochester, MN 55905.

© 2000  Mosby, Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer

Vol 106 - N° 3

P. 521-529 - septembre 2000 Retour au numéro
Article précédent Article précédent
  • The relationship between serum IgE and surface levels of FcϵR on human leukocytes in various diseases: Correlation of expression with FcϵRI on basophils but not on monocytes or eosinophils
  • Sarbjit S. Saini, Amy D. Klion, Steven M. Holland, Robert G. Hamilton, Bruce S. Bochner, Donald W. MacGlashan
| Article suivant Article suivant
  • Transplacental priming of the human immune system with environmental allergens can occur early in gestation
  • Zsolt Szépfalusi, Josefa Pichler, Stefan Elsässer, Katalin van Duren, Christof Ebner, Georg Bernaschek, Radvan Urbanek

Bienvenue sur EM-consulte,
la référence des professionnels de santé.

Plus de 500 000 articles médicaux,
paramédicaux et scientifiques vous attendent.

Déjà abonné à cette revue ?